Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Muhammad Aftab to Erythropoietin

This is a "connection" page, showing publications Muhammad Aftab has written about Erythropoietin.

 
Connection Strength
 
 
 
0.562
 
  1. Yamanaka K, Eldeiry M, Roda G, Aftab M, Reece TB. Potential benefit of pharmacological induction of beta common receptor. J Thorac Cardiovasc Surg. 2018 11; 156(5):1796-1797.
    View in: PubMed
    Score: 0.143
  2. Yamanaka K, Eldeiry M, Aftab M, Ryan TJ, Mares J, Meng X, Weyant MJ, Cleveland JC, Fullerton DA, Reece TB. Synergistic Reduction of Apoptosis With Diazoxide and Erythropoietin in Spinal Cord Ischemic Injury. Ann Thorac Surg. 2018 12; 106(6):1751-1758.
    View in: PubMed
    Score: 0.142
  3. Yamanaka K, Eldeiry M, Aftab M, Ryan TJ, Meng X, Weyant MJ, Fullerton DA, Reece TB. Synergetic Induction of NGF With Diazoxide and Erythropoietin Attenuates Spinal Cord Ischemic Injury. J Surg Res. 2019 01; 233:124-131.
    View in: PubMed
    Score: 0.141
  4. Yamanaka K, Eldeiry M, Aftab M, Mares J, Ryan TJ, Meng X, Weyant MJ, Cleveland JC, Fullerton DA, Reece TB. Optimized induction of beta common receptor enhances the neuroprotective function of erythropoietin in spinal cord ischemic injury. J Thorac Cardiovasc Surg. 2018 06; 155(6):2505-2516.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)